QPS Assay Finder
VALIDATED ASSAYS QPS
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
SEARCH FOR AN ASSAY HERE!
Found 835 Results
17-Desacetyl Norgestimate (Norelgestromin) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.02 – 10 ng/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Birth Control |
| Classification: | Drug Assays |
17α-Ethynylestradiol (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 5.00 – 500 pg/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Birth Control |
| Classification: | Drug Assays |
17α-Ethynylestradiol Levonorgestrel (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 5.00 – 500 pg/mL200 – 20,000 pg/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Birth Control |
| Classification: | Drug Assays |
19-Norandrosterone19-Norethiocholanolone (Matrix: Human Urine)
| Matrix: | Human Urine |
| Assay Range: | 0.600 – 60.0 ng/mL |
| Sample Volume: | 5 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Birth Control |
| Classification: | Drug Assays |
4-Butylamino-benzoic acid (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 5,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Drug Assays |
4-Phenylbutyric acid (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 200 µg/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
5-Fluorouracil (5-FU) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 3,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
5-Fluorouracil (5-FU)
Capecitabine (Matrix: Human Plasma)
Capecitabine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5.00 – 2,000 ng/mL 25.0 – 5,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTAHeparin |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
5-Fluorouracil (5-FU)
Capecitabine
Doxifluridine (Matrix: Human Plasma)
Capecitabine
Doxifluridine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5.00 – 2,000 ng/mL 25.0 – 2,000 mg/mL 25.0 – 2,000 mg/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTAHeparin |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
6-Methoxy-2-Naphthylacetic acid (Nebumetane) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.5 – 75 µg/ml |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | HPLC |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | NSAID |
| Classification: | Drug Assays |
Abacavir (ABC) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 5,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Abacavir (ABC) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 10,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Abacavir (ABC)
Lamivudine (3TC) (Matrix: Human Plasma)
Lamivudine (3TC) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 12,000 ng/mL-15 – 6,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Abeta (Aß) Total (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 100 – 8,000 pg/mL |
| Sample Volume: | 0.025 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | ECL (MSD) |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Alzheimer’s Disease |
| Classification: | Biochemical Biomarkers |
Abeta (Aß) Total (Matrix: Human CSF)
| Matrix: | Human CSF |
| Assay Range: | 200 – 10,000 pg/mL |
| Sample Volume: | 0.025 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | ECL (MSD) |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Alzheimer’s Disease |
| Classification: | Biochemical Biomarkers |
Abiraterone (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 500 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | FluorideOxalate |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Abiraterone (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 200 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Abiraterone (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 1,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Acarbose (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 3.00 – 1,000 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Anti-diabetic |
| Classification: | Drug Assays |
Acarbose (Matrix: Human Urine)
| Matrix: | Human Urine |
| Assay Range: | 3.00 – 1,000 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Anti-diabetic |
| Classification: | Drug Assays |
Acetaminophen (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 100 μg/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drug Assays |
Acetaminophen (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 75 – 20,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drug Assays |
Acetaminophen Dextromethorphan Dextrorphan (Matrix: Dog Plasma)
| Matrix: | Dog Plasma |
| Assay Range: | 1 – 500 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drug Assays |
Acetaminophen Dextromethorphan Dextrorphan (Matrix: Rat Plasma)
| Matrix: | Rat Plasma |
| Assay Range: | 10 – 5,000 ng/mL1 – 500 ng/mL1 – 500 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Respiratory |
| Classification: | Drug Assays |
Acetaminophen Propoxyphene (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 50 – 2,000 ng/mL 1 – 400 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Analgesic |
| Classification: | Drug Assays |
DOWNLOAD THE FREE APPLE OR ANDROID APP HERE!
